Document is current

Any future updates will be listed below

High prevalence of potential drug-drug interactions in patients with castration-resistant prostate cancer treated with abiraterone acetate

Crossref DOI link: https://doi.org/10.1007/s00228-016-2120-3

Published Online: 2016-08-25

Published Print: 2016-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark